Engineering an in situ crosslinkable hydrogel for enhanced remyelination

Xiaowei Li, Xiaoyan Liu, Lin Cui, Christopher Brunson, Wen Zhao, Narayan R. Bhat, Ning Zhang, Xuejun Wen

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Remyelination has to occur to fully regenerate injured spinal cords or brain tissues. A growing body of evidence has suggested that exogenous cell transplantation is one promising strategy to promote remyelination. However, direct injection of neural stem cells or oligodendrocyte progenitor cells (OPCs) to the lesion site may not be an optimal therapeutic strategy due to poor viability and functionality of transplanted cells resulted from the local hostile tissue environment. The overall objective of this study was to engineer an injectable biocompatible hydrogel system as a supportive niche to provide a regeneration permissive microenvironment for transplanted OPCs to survive, functionally differentiate, and remyelinate central nervous system (CNS) lesions. A highly biocompatible hydrogel, based on thiol-functionalized hyaluronic acid and thiolfunctionalized gelatin, which can be crosslinked by poly-(ethylene glycol) diacrylate (PEGDA), was used. These hydrogels were optimized first regarding cell adhesive properties and mechanical properties to best support the growth properties of OPCs in culture. Transplanted OPCs with the hydrogels optimized in vitro exhibited enhanced survival and oligodendrogenic differentiation and were able to remyelinate demyelinated axons inside ethidium bromide (EB) demyelination lesion in adult spinal cord. This study provides a new possible therapeutic approach to treat CNS injuries in which cell therapies may be essential.

Original languageEnglish (US)
Pages (from-to)1127-1136
Number of pages10
JournalFASEB Journal
Volume27
Issue number3
DOIs
StatePublished - Mar 1 2013

Fingerprint

Hydrogels
Hydrogel
Oligodendroglia
Neurology
Stem Cells
Tissue
Ethidium
Direct injection
Hyaluronic Acid
Gelatin
Stem cells
Sulfhydryl Compounds
Brain
Adhesives
Spinal Cord
Central Nervous System
Nervous System Trauma
Engineers
Mechanical properties
Injections

Keywords

  • Biomaterials
  • Oligodendrocyte progenitor cells
  • Spinal cord regeneration
  • Transplantation

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Li, X., Liu, X., Cui, L., Brunson, C., Zhao, W., Bhat, N. R., ... Wen, X. (2013). Engineering an in situ crosslinkable hydrogel for enhanced remyelination. FASEB Journal, 27(3), 1127-1136. https://doi.org/10.1096/fj.12-211151

Engineering an in situ crosslinkable hydrogel for enhanced remyelination. / Li, Xiaowei; Liu, Xiaoyan; Cui, Lin; Brunson, Christopher; Zhao, Wen; Bhat, Narayan R.; Zhang, Ning; Wen, Xuejun.

In: FASEB Journal, Vol. 27, No. 3, 01.03.2013, p. 1127-1136.

Research output: Contribution to journalArticle

Li, X, Liu, X, Cui, L, Brunson, C, Zhao, W, Bhat, NR, Zhang, N & Wen, X 2013, 'Engineering an in situ crosslinkable hydrogel for enhanced remyelination', FASEB Journal, vol. 27, no. 3, pp. 1127-1136. https://doi.org/10.1096/fj.12-211151
Li, Xiaowei ; Liu, Xiaoyan ; Cui, Lin ; Brunson, Christopher ; Zhao, Wen ; Bhat, Narayan R. ; Zhang, Ning ; Wen, Xuejun. / Engineering an in situ crosslinkable hydrogel for enhanced remyelination. In: FASEB Journal. 2013 ; Vol. 27, No. 3. pp. 1127-1136.
@article{75bd66ab7b174d4f9b6bf305d7088c93,
title = "Engineering an in situ crosslinkable hydrogel for enhanced remyelination",
abstract = "Remyelination has to occur to fully regenerate injured spinal cords or brain tissues. A growing body of evidence has suggested that exogenous cell transplantation is one promising strategy to promote remyelination. However, direct injection of neural stem cells or oligodendrocyte progenitor cells (OPCs) to the lesion site may not be an optimal therapeutic strategy due to poor viability and functionality of transplanted cells resulted from the local hostile tissue environment. The overall objective of this study was to engineer an injectable biocompatible hydrogel system as a supportive niche to provide a regeneration permissive microenvironment for transplanted OPCs to survive, functionally differentiate, and remyelinate central nervous system (CNS) lesions. A highly biocompatible hydrogel, based on thiol-functionalized hyaluronic acid and thiolfunctionalized gelatin, which can be crosslinked by poly-(ethylene glycol) diacrylate (PEGDA), was used. These hydrogels were optimized first regarding cell adhesive properties and mechanical properties to best support the growth properties of OPCs in culture. Transplanted OPCs with the hydrogels optimized in vitro exhibited enhanced survival and oligodendrogenic differentiation and were able to remyelinate demyelinated axons inside ethidium bromide (EB) demyelination lesion in adult spinal cord. This study provides a new possible therapeutic approach to treat CNS injuries in which cell therapies may be essential.",
keywords = "Biomaterials, Oligodendrocyte progenitor cells, Spinal cord regeneration, Transplantation",
author = "Xiaowei Li and Xiaoyan Liu and Lin Cui and Christopher Brunson and Wen Zhao and Bhat, {Narayan R.} and Ning Zhang and Xuejun Wen",
year = "2013",
month = "3",
day = "1",
doi = "10.1096/fj.12-211151",
language = "English (US)",
volume = "27",
pages = "1127--1136",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

TY - JOUR

T1 - Engineering an in situ crosslinkable hydrogel for enhanced remyelination

AU - Li, Xiaowei

AU - Liu, Xiaoyan

AU - Cui, Lin

AU - Brunson, Christopher

AU - Zhao, Wen

AU - Bhat, Narayan R.

AU - Zhang, Ning

AU - Wen, Xuejun

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Remyelination has to occur to fully regenerate injured spinal cords or brain tissues. A growing body of evidence has suggested that exogenous cell transplantation is one promising strategy to promote remyelination. However, direct injection of neural stem cells or oligodendrocyte progenitor cells (OPCs) to the lesion site may not be an optimal therapeutic strategy due to poor viability and functionality of transplanted cells resulted from the local hostile tissue environment. The overall objective of this study was to engineer an injectable biocompatible hydrogel system as a supportive niche to provide a regeneration permissive microenvironment for transplanted OPCs to survive, functionally differentiate, and remyelinate central nervous system (CNS) lesions. A highly biocompatible hydrogel, based on thiol-functionalized hyaluronic acid and thiolfunctionalized gelatin, which can be crosslinked by poly-(ethylene glycol) diacrylate (PEGDA), was used. These hydrogels were optimized first regarding cell adhesive properties and mechanical properties to best support the growth properties of OPCs in culture. Transplanted OPCs with the hydrogels optimized in vitro exhibited enhanced survival and oligodendrogenic differentiation and were able to remyelinate demyelinated axons inside ethidium bromide (EB) demyelination lesion in adult spinal cord. This study provides a new possible therapeutic approach to treat CNS injuries in which cell therapies may be essential.

AB - Remyelination has to occur to fully regenerate injured spinal cords or brain tissues. A growing body of evidence has suggested that exogenous cell transplantation is one promising strategy to promote remyelination. However, direct injection of neural stem cells or oligodendrocyte progenitor cells (OPCs) to the lesion site may not be an optimal therapeutic strategy due to poor viability and functionality of transplanted cells resulted from the local hostile tissue environment. The overall objective of this study was to engineer an injectable biocompatible hydrogel system as a supportive niche to provide a regeneration permissive microenvironment for transplanted OPCs to survive, functionally differentiate, and remyelinate central nervous system (CNS) lesions. A highly biocompatible hydrogel, based on thiol-functionalized hyaluronic acid and thiolfunctionalized gelatin, which can be crosslinked by poly-(ethylene glycol) diacrylate (PEGDA), was used. These hydrogels were optimized first regarding cell adhesive properties and mechanical properties to best support the growth properties of OPCs in culture. Transplanted OPCs with the hydrogels optimized in vitro exhibited enhanced survival and oligodendrogenic differentiation and were able to remyelinate demyelinated axons inside ethidium bromide (EB) demyelination lesion in adult spinal cord. This study provides a new possible therapeutic approach to treat CNS injuries in which cell therapies may be essential.

KW - Biomaterials

KW - Oligodendrocyte progenitor cells

KW - Spinal cord regeneration

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=84874608911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874608911&partnerID=8YFLogxK

U2 - 10.1096/fj.12-211151

DO - 10.1096/fj.12-211151

M3 - Article

VL - 27

SP - 1127

EP - 1136

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -